These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34303542)

  • 1. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
    Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
    Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
    BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical determinants of malignant transformation in oral epithelial dysplasia.
    Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
    Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
    Mahmood H; Shephard A; Hankinson P; Bradburn M; Araujo ALD; Santos-Silva AR; Lopes MA; Vargas PA; McCombe KD; Craig SG; James J; Brooks J; Nankivell P; Mehanna H; Rajpoot N; Khurram SA
    Br J Cancer; 2023 Nov; 129(10):1599-1607. PubMed ID: 37758836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of oral leukoplakia: a follow-up study.
    Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
    Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases.
    Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A
    Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
    Müller S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of specific clinical risk factors associated with the malignant transformation of oral epithelial dysplasia.
    Kierce J; Shi Y; Klieb H; Blanas N; Xu W; Magalhaes M
    Head Neck; 2021 Nov; 43(11):3552-3561. PubMed ID: 34472151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters.
    Wang YP; Chen IC; Wu YH; Wu YC; Chen HM; Yu-Fong Chang J
    J Formos Med Assoc; 2017 Jun; 116(6):457-463. PubMed ID: 28292622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?
    Pritzker KPH; Darling MR; Hwang JT; Mock D
    Expert Rev Mol Diagn; 2021 Mar; 21(3):289-298. PubMed ID: 33682567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral precursor lesions and malignant transformation--who, where, what, and when?
    Goodson ML; Sloan P; Robinson CM; Cocks K; Thomson PJ
    Br J Oral Maxillofac Surg; 2015 Nov; 53(9):831-5. PubMed ID: 26388071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of oral epithelial dysplasia in Southwest Finland.
    Nevanpää TT; Terävä AE; Laine HK; Rautava J
    Sci Rep; 2022 May; 12(1):8261. PubMed ID: 35585112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Architectural and cytological features of epithelial dysplasia associated with transformation risk.
    Cai X; Zhang J; Zhang H; Zhou X; Zhou Z; Jing F; Luo H; Li T
    Oral Dis; 2024 Jul; 30(5):3028-3038. PubMed ID: 37983891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia.
    Gan CP; Lee BKB; Lau SH; Kallarakkal TG; Zaini ZM; Lye BKW; Zain RB; Sathasivam HP; Yeong JPS; Savelyeva N; Thomas G; Ottensmeier CH; Ariffin H; Cheong SC; Lim KP
    Front Immunol; 2022; 13():954567. PubMed ID: 36119104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.